At Kindeva, our purpose is clear: manufacturing more tomorrows for patients worldwide.
By investing in the highest quality facilities, finished-dose CDMO solutions and analytical capabilities, we provide strategic value that extends beyond manufacturing. Our global network of 10 manufacturing and R&D facilities offers exceptional capabilities, including expanded aseptic fill finish capacity and next-generation green propellant technologies. We leverage our sterile injectable, pulmonary, nasal and dermal expertise to help meet the demands of today and deliver the possibilities of tomorrow.